Edaravone is a neuroprotective drug primarily used to treat acute ischemic stroke and amyotrophic lateral sclerosis (ALS). Developed in the 1980s and approved for medical use in Japan in 2001 (stroke) and later for ALS in 2015, its history is marked by its role in reducing oxidative stress in neurons. Edaravone acts as a free radical scavenger, limiting neuronal damage caused by reactive oxygen species, which are implicated in neurodegenerative processes and ischemic injury. Its development emphasized rigorous clinical evaluation, and it is administered under strict monitoring protocols to ensure safety and efficacy, particularly in patients with compromised renal or hepatic function.
BRAND NAMES
Radicava – primarily used for amyotrophic lateral sclerosis (ALS)
MCI-186 – used in some research contexts and early clinical trials
Radicut – marketed in Japan for acute ischemic stroke.
MECHANISM OF ACTION
Edaravone is a potent free radical scavenger that exerts neuroprotective effects by reducing oxidative stress in neurons. It neutralizes reactive oxygen species, such as hydroxyl radicals and peroxynitrite, which are produced during ischemic injury or neurodegenerative processes like amyotrophic lateral sclerosis (ALS).
PHARMACOKINETICS
Absorption
Edaravone is administered intravenously, as oral absorption is limited. Following IV administration, it is rapidly distributed into the bloodstream, achieving peak plasma concentrations almost immediately after infusion.
Distribution
After intravenous administration, edaravone is widely distributed throughout the body, including the central nervous system, where it exerts its neuroprotective effects. It is moderately bound to plasma proteins, primarily albumin, which helps maintain circulating levels.
Metabolism
Edaravone undergoes extensive hepatic metabolism, primarily through conjugation reactions such as glucuronidation and sulfation, forming inactive metabolites. A minor portion is also oxidized.
Elimination
Edaravone and its metabolites are primarily excreted via the urine, with a small fraction eliminated in the feces. The plasma half-life of edaravone is approximately 4.5 to 6 hours, allowing for twice-daily or daily dosing depending on the indication.
PHARMACODYNAMICS
Pharmacodynamics is the branch of pharmacology that studies what a drug does to the body and how it produces its effects. It focuses on the mechanism of drug action, primarily through interactions with cellular receptors, enzymes, or ion channels, leading to a physiological or biochemical response. Drugs can act as agonists, activating receptors, or antagonists, blocking them, and their effects depend on both the dose and the sensitivity of the target tissue.
ADMINISTRATION
Administration is how a drug is given to the body to produce its effect. Common routes include oral, injection, topical, inhalation, and sublingual. The route affects how fast and how strongly the drug works, and is chosen based on the drug’s properties and patient needs.
DOSAGE AND STRENGTH
Dosage and strength refer to the amount of a drug given and its concentration in a formulation to achieve the desired therapeutic effect safely. Dosage considers factors like age, weight, health condition, and severity of illness, ensuring the drug is effective without causing toxicity.
DRUG INTERACTIONS
Drug interactions occur when one drug affects the action or effectiveness of another, potentially increasing side effects or reducing therapeutic effects. They can be pharmacokinetic, altering how a drug is absorbed, distributed, metabolized, or excreted; pharmacodynamic, changing the drug’s effect at its target site; or involve food and supplements, which can affect drug levels or activity.
FOOD INTERACTIONS
Food interactions occur when the food or drink a person consumes affects a drug’s absorption, metabolism, or action. Some foods can increase or decrease drug effectiveness or cause side effects. For example, grapefruit juice can block enzymes that metabolize certain drugs, increasing their blood levels, while dairy products can reduce the absorption of some antibiotics.
CONTRAINDICATIONS
Contraindications are specific conditions or factors that make a particular drug or treatment unsafe for a patient. They indicate situations where a drug should not be used because it may cause harm or worsen a medical condition.
SIDE EFFECTS
Unintended effects of a drug besides its main therapeutic action.
Can be mild (e.g., nausea, dizziness) or severe (e.g., allergic reactions, organ damage).
May be predictable or unpredictable (idiosyncratic).
Monitoring and dose adjustment help manage and reduce risks.
TOXICITY
Toxicity refers to the harmful effects of a drug or chemical when it is taken in excessive amounts or over a prolonged period. It occurs when the drug’s concentration exceeds the body’s ability to safely process it, leading to adverse reactions or organ damage.
